176 related articles for article (PubMed ID: 26166774)
21. The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules.
Burnet NG; Nyman J; Turesson I; Wurm R; Yarnold JR; Peacock JH
Radiother Oncol; 1994 Dec; 33(3):228-38. PubMed ID: 7716263
[TBL] [Abstract][Full Text] [Related]
22. Does variability in normal tissue reactions after radiotherapy have a genetic basis--where and how to look for it?
Andreassen CN; Alsner J; Overgaard J
Radiother Oncol; 2002 Aug; 64(2):131-40. PubMed ID: 12242122
[TBL] [Abstract][Full Text] [Related]
23. Tumour and normal tissue radiosensitivity.
Lapierre A; Gourgou S; Brengues M; Quéro L; Deutsch É; Milliat F; Riou O; Azria D
Cancer Radiother; 2022; 26(1-2):96-103. PubMed ID: 34953704
[TBL] [Abstract][Full Text] [Related]
24. In vitro cellular radiosensitivity in relationship to late normal tissue reactions in breast cancer patients: a multi-endpoint case-control study.
Vandevoorde C; Depuydt J; Veldeman L; De Neve W; Sebastià N; Wieme G; Baert A; De Langhe S; Philippé J; Thierens H; Vral A
Int J Radiat Biol; 2016 Dec; 92(12):823-836. PubMed ID: 27586010
[TBL] [Abstract][Full Text] [Related]
25. Describing patients' normal tissue reactions: concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity. Steering Committee of the BioMed2 European Union Concerted Action Programme on the Development of Predictive Tests of Normal Tissue Response to Radiation Therapy.
Burnet NG; Johansen J; Turesson I; Nyman J; Peacock JH
Int J Cancer; 1998 Dec; 79(6):606-13. PubMed ID: 9842969
[TBL] [Abstract][Full Text] [Related]
26. A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.
Barnett GC; Thompson D; Fachal L; Kerns S; Talbot C; Elliott RM; Dorling L; Coles CE; Dearnaley DP; Rosenstein BS; Vega A; Symonds P; Yarnold J; Baynes C; Michailidou K; Dennis J; Tyrer JP; Wilkinson JS; Gómez-Caamaño A; Tanteles GA; Platte R; Mayes R; Conroy D; Maranian M; Luccarini C; Gulliford SL; Sydes MR; Hall E; Haviland J; Misra V; Titley J; Bentzen SM; Pharoah PD; Burnet NG; Dunning AM; West CM
Radiother Oncol; 2014 May; 111(2):178-85. PubMed ID: 24785509
[TBL] [Abstract][Full Text] [Related]
27. Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in NSCLC.
Scott JG; Sedor G; Scarborough JA; Kattan MW; Peacock J; Grass GD; Mellon EA; Thapa R; Schell M; Waller A; Poppen S; Andl G; Teer JK; Eschrich SA; Dilling TJ; Dalton WS; Harrison LB; Fox T; Torres-Roca JF
J Thorac Oncol; 2021 Mar; 16(3):428-438. PubMed ID: 33301984
[TBL] [Abstract][Full Text] [Related]
28. How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity?
Tucker SL; Geara FB; Peters LJ; Brock WA
Radiother Oncol; 1996 Feb; 38(2):103-13. PubMed ID: 8966222
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide association studies and prediction of normal tissue toxicity.
West CM; Dunning AM; Rosenstein BS
Semin Radiat Oncol; 2012 Apr; 22(2):91-9. PubMed ID: 22385916
[No Abstract] [Full Text] [Related]
30. Genetic markers for prediction of normal tissue toxicity after radiotherapy.
Alsner J; Andreassen CN; Overgaard J
Semin Radiat Oncol; 2008 Apr; 18(2):126-35. PubMed ID: 18314067
[TBL] [Abstract][Full Text] [Related]
31. Normal tissue radiosensitivity: prediction on deterministic or stochastic basis?
Awwad HK
J Egypt Natl Canc Inst; 2005 Dec; 17(4):221-30. PubMed ID: 17102816
[TBL] [Abstract][Full Text] [Related]
32. Proteomic approaches to identify biomarkers predictive of radiotherapy outcomes.
Lacombe J; Azria D; Mange A; Solassol J
Expert Rev Proteomics; 2013 Feb; 10(1):33-42. PubMed ID: 23414358
[TBL] [Abstract][Full Text] [Related]
33. Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy.
Borgmann K; Hoeller U; Nowack S; Bernhard M; Röper B; Brackrock S; Petersen C; Szymczak S; Ziegler A; Feyer P; Alberti W; Dikomey E
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):256-64. PubMed ID: 18406889
[TBL] [Abstract][Full Text] [Related]
34. Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity.
Bentzen SM; Overgaard M; Overgaard J
Eur J Cancer; 1993; 29A(10):1373-6. PubMed ID: 8398261
[TBL] [Abstract][Full Text] [Related]
35. Biological basis of radiation sensitivity. Part 2: Cellular and molecular determinants of radiosensitivity.
Rosen EM; Fan S; Goldberg ID; Rockwell S
Oncology (Williston Park); 2000 May; 14(5):741-57; discussion 757-8, 761-6. PubMed ID: 10853463
[TBL] [Abstract][Full Text] [Related]
36. Intrinsic Radiosensitivity and Cellular Characterization of 27 Canine Cancer Cell Lines.
Maeda J; Froning CE; Brents CA; Rose BJ; Thamm DH; Kato TA
PLoS One; 2016; 11(6):e0156689. PubMed ID: 27257868
[TBL] [Abstract][Full Text] [Related]
37. Compromized DNA repair as a basis for identification of cancer radiotherapy patients with extreme radiosensitivity.
Lobachevsky P; Leong T; Daly P; Smith J; Best N; Tomaszewski J; Thompson ER; Li N; Campbell IG; Martin RF; Martin OA
Cancer Lett; 2016 Dec; 383(2):212-219. PubMed ID: 27693457
[TBL] [Abstract][Full Text] [Related]
38. Radiation therapy tolerance limits. For one or for all?--Janeway Lecture.
Peters LJ
Cancer; 1996 Jun; 77(11):2379-85. PubMed ID: 8635110
[TBL] [Abstract][Full Text] [Related]
39. Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.
Andreassen CN; Rosenstein BS; Kerns SL; Ostrer H; De Ruysscher D; Cesaretti JA; Barnett GC; Dunning AM; Dorling L; West CML; Burnet NG; Elliott R; Coles C; Hall E; Fachal L; Vega A; Gómez-Caamaño A; Talbot CJ; Symonds RP; De Ruyck K; Thierens H; Ost P; Chang-Claude J; Seibold P; Popanda O; Overgaard M; Dearnaley D; Sydes MR; Azria D; Koch CA; Parliament M; Blackshaw M; Sia M; Fuentes-Raspall MJ; Ramon Y Cajal T; Barnadas A; Vesprini D; Gutiérrez-Enríquez S; Mollà M; Díez O; Yarnold JR; Overgaard J; Bentzen SM; Alsner J;
Radiother Oncol; 2016 Dec; 121(3):431-439. PubMed ID: 27443449
[TBL] [Abstract][Full Text] [Related]
40. Association between SNPs in defined functional pathways and risk of early or late toxicity as well as individual radiosensitivity.
Reuther S; Szymczak S; Raabe A; Borgmann K; Ziegler A; Petersen C; Dikomey E; Hoeller U
Strahlenther Onkol; 2015 Jan; 191(1):59-66. PubMed ID: 25156511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
